Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary langerhans cell histiocytosis

Mayo Clinic Proceedings

Volumn 79, Issue 10, 2004, Pages 1269-1275

  Chaowalit, Nithima ^a   Pellikka, Patricia A ^a   Decker, Paul A ^a   Aubry, Marie Christine ^a   Krowka, Michael J ^a   Ryu, Jay H ^a   Vassallo, Robert ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HISTIOCYTOSIS X; HUMAN; HUMAN TISSUE; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PULMONARY HYPERTENSION; SCREENING;

EID: 4644237044     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.10.1269     Document Type: Article

References (17)

1. Tazi A, Soler P, Hance AJ. Adult pulmonary Langerhans' cell histiocytosis. Thorax. 2000;55:405-416.
2. Vassallo R, Ryu JH, Colby TV, Hartman T, Limper AH. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med. 2000;342:1969-1978.
3. Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med. 2002;346:484-490.
4. Maloney JP. Advances in the treatment of secondary pulmonary hypertension. Curr Opin Pulm Med. 2003;9:139-143.
5. Travis WD, Borok Z, Roum JH, et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X): a clinicopathologic study of 48 cases. Am J Surg Pathol. 1993;17:971-986.
6. Harari S, Brenot F, Barberis M, Simmoneau G. Advanced pulmonary histiocytosis X is associated with severe pulmonary hypertension [letter]. Chest. 1997;111:1142-1144.
7. Fartoukh M, Humbert M, Capron F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med. 2000;161:216-223.
8. Tajik AJ, Seward JB, Hagler DJ, Mair DD, Lie JT. Two-dimensional real-time ultrasonic imaging of the heart and great vessels: technique, image orientation, structure identification, and validation. Mayo Clin Proc. 1978;53: 271-303.
9. Nishimura RA, Miller FA Jr, Callahan MJ, Benassi RC, Seward JB, Tajik AJ. Doppler echocardiography: theory, instrumentation, technique, and application. Mayo Clin Proc. 1985;60:321-343.
10. Currie PJ, Seward JB, Chan KL, et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler- catheterization study in 127 patients. J Am Coll Cardiol. 1985;6:750-756.
11. Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol. 1990;66:493-496.
12. Schiller NB, Shah PM, Crawford M, et al, American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358-367.
13. Tei C, Nishimura RA, Seward JB, Tajik AJ. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr. 1997;10:169-178.
14. Crausman RS, King TE Jr. Pulmonary vascular involvement in pulmonary histiocytosis X [letter]. Chest. 1997;112:1714.
15. Crausman RS, Jennings CA, Tuder RM, Ackerson LM, Irvin CG, King TE Jr. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med. 1996;153:426-435.
16. Hamada K, Teramoto S, Narita N, Yamada E, Teramoto K, Kobzik L. Pulmonary veno-occlusive disease in pulmonary Langerhans' cell granulomatosis. Eur Respir J. 2000;15:421-423.
17. Colby TV, Lombard C. Histiocytosis X in the lung. Hum Pathol. 1983;14:847-856.